TAKE THIS POLL |
|
|
- Bleakest prognosis comes from overseas 5 Jul 2008 09:16 GMT
... Royal Bank of Scotland, Barclays warn clients about remainder of 2008 ... Pfizer, Merck, Wyeth, Johnson & Johnson and Abbott Labs in the U.S. and Glaxo, Roche ...
- Baby Drinks in North America to 2011 - New Research Report on Companies and Markets 4 Jul 2008 22:57 GMT
... company in the market in 2006 was Mead Johnson Nutritionals. The second-largest player was Abbott Laboratories with Nestle S.A. is third place. Reasons to Purchase Discover the major quantitative ...
- Global Baby Drinks market to 2011 - New Research Report on Companies and Markets 4 Jul 2008 22:57 GMT
... in 2006 was Mead Johnson Nutritionals . The second-largest player was Nestle S.A. with Abbott Laboratories is third place. Reasons to Purchase Discover the major quantitative trends affecting the ...
- Study finds people with HIV living longer 4 Jul 2008 21:11 GMT
... AIDS drugs include GlaxoSmithKline, Gilead Sciences Inc, Roche, Pfizer, Merck Inc, Bristol-Myers Squibb and Abbott Laboratories. The British team compared the death risk in the five years following infection ...
- TFN economic and business calendar to Friday July 18 4 Jul 2008 15:11 GMT
... (1315 GMT) -June Cleveland Fed Median CPI (1500 GMT) -NJ employment, unemployment (2030 GMT) -Abbott Laboratories Q2 results. EPS forecast $0.79 versus $0.69 (before market opens) -Ebay Inc Q2 ...
- SkyePharma soars as third Flutiform trial hits endpoints 4 Jul 2008 11:36 GMT
... US filing”. This is being conducted by partner Kos Life Sciences, a unit of Abbott Laboratories, and that is on track “to be fully recruited in July and completed ...
- Asian economic and business calendar -- to July 21 4 Jul 2008 10:28 GMT
... -U.S. June Cleveland Fed Median CPI (1500 GMT) -U.S. NJ employment, unemployment (2030 GMT) -Abbott Laboratories Q2 results. EPS forecast $0.79 versus $0.69 (before market opens) -Ebay Inc Q2 ...
- Would a stent by any other name sell as well? 4 Jul 2008 06:26 GMT
... for use the new Xience V stent for propping open coronary arteries from Illinois-based Abbott Laboratories. As part of the approval, Natick, Mass.-based Boston Scientific can sell the very ...
- Safer, more effective stents will be available next week for patients with clogged arteries 4 Jul 2008 00:56 GMT
... superior in the most recent trial is called Xience V and is made by Abbott Laboratories. "Since the introduction of the first generation of drug-eluting stents, thinner stents have ...
- GlaxoSmithKline, Novartis to appeal $114 million verdict in Alabama drug price lawsuits 3 Jul 2008 23:59 GMT
... of the state's lawsuits against drug companies Bristol-Myers Squibb Co., Novartis subsidiary Sandoz and Abbott Laboratories is scheduled to begin Oct. 27 in Montgomery. Officials with Bristol-Meyer Squibb and ...
- 2 drug firms to appeal $114M price fraud verdict 3 Jul 2008 22:56 GMT
... state's lawsuits against drug companies Bristol-Myers Squibb Co. ( ), Novartis subsidiary Sandoz and Abbott Laboratories is scheduled to begin Oct. 27 in Montgomery. Officials with Bristol-Meyer Squibb and ...
- FDA approves Boston Scientific stent 3 Jul 2008 20:36 GMT
... company's Promus drug-coated coronary stent. The Promus stent is manufactured by Abbott Park, Ill.-based Abbott Laboratories under the name Xience V and distributed by Boston Scientific under an agreement ...
- New Drug-Coated Stent Approved 3 Jul 2008 19:55 GMT
... coronary artery disease, has been approved by the U.S. Food and Drug Administration, maker Abbott Laboratories said. A stent is a metal-mesh tube that's inserted into the artery. The ...
- Abbott Laboratories Get FDA Approval For Drug-Coated Stent Xience V 3 Jul 2008 18:31 GMT
... ...
- How Can You Profit From Earnings Season Today? 3 Jul 2008 18:29 GMT
... could hold up through this earnings season. Abbott Laboratories is engaged in the discovery, development, ... want to consider a hedged trade on ABT. Look at the August 50/47.50 Bull Put ...
- Alcoa, Abbott Laboratories, L-3 Communications, and Merrill Lynch 3 Jul 2008 17:27 GMT
... approval of a stent from Abbot Laboratories (ABT). Here is what you need to know ... the drug-coated Xience V stent, produced by Abbott Laboratories ( ) . ABT believes that ...
- Comtex SmarTrend(R) Morning Call -- July 3, 2008 3 Jul 2008 17:23 GMT
... Jul 03, 2008 (SmarTrend® via COMTEX) -- There are some early ... including a disappointing ADP report, General Motors (NYSE:GM) viability questions, dropping oil prices, and more ... sales expected to post at $875-$950 million... Abbott Labs (NYSE:ABT) received FDA approved of its Xience ...
- S&P Picks and Pans: Freddie, Abbott, JetBlue, ING 3 Jul 2008 17:17 GMT
... S&P REITERATES BUY OPINION ON SHARES OF ABBOTT LABORATORIES FDA approves Xience drug-coated stent, as ... also launching its Xience-like Promus stent, with ABT to receive 40% of Promus sales. Given ...
- Abbott rises after FDA approves Xience V stent 3 Jul 2008 16:34 GMT
... Abbott rises after FDA approves Xience V stent NEW YORK - Shares of Abbott Laboratories rose Thursday after regulators approved its drug-coated Xience V stent for sale. The ...
- S&P Picks and Pans: Abbott Labs, JetBlue, ING, Georgia Gulf 3 Jul 2008 16:33 GMT
... S&P REITERATES BUY OPINION ON SHARES OF ABBOTT LABORATORIES FDA approves Xience drug-coated stent, as ... also launching its Xience-like Promus stent, with ABT to receive 40% of Promus sales. Given ...
- TFN economic and business calendar to Thursday July 17 3 Jul 2008 15:31 GMT
... (1315 GMT) -June Cleveland Fed Median CPI (1500 GMT) -NJ employment, unemployment (2030 GMT) -Abbott Laboratories Q2 results. EPS forecast $0.79 versus $0.69 (before market opens) -Ebay Inc Q2 ...
- Alcoa, Abbott Laboratories, Level 3 Communications, and Merrill Lynch 3 Jul 2008 15:27 GMT
... approval of a stent from Abbot Laboratories (ABT). Here is what you need to know ... the drug-coated Xience V stent, produced by Abbott Laboratories ( ) . ABT believes that ...
- New PriceWatch Alerts for QCOM, POT, S, LEN, BID 3 Jul 2008 14:36 GMT
... assigned* -- Potash Corp. of Saskatchewan, Inc. (NYSE: POT) Last Price 212.55 - JUL 210.00 ... LEADERS AND So far today, Dell Inc., Abbott Laboratories, and The Talbots Inc. lead the list ...
- Opening Glance: Medical devices 3 Jul 2008 14:35 GMT
... Scientific Corp., up 8 cents to $12.49. Medtronic Inc., up 4 cents to $50.98. Abbott Laboratories, up 69 cents to $54.93. Copyright 2008 Associated Press. All rights reserved. This ...
- BioCurex Comments On Market Activity 3 Jul 2008 14:19 GMT
... benign cells. BioCurex has signed licensing agreements for its cancer detection blood tests with Abbott Laboratories and with Inverness Medical Innovations The cancer marker RECAF(tm) has emerged as a ...
1 - 25 of 216 next >
News by PR Newswire
|